The progression of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic in Africa has so far been heterogeneous, and the full impact is not yet well understood…

Here, we report SARS-CoV-2 genomic surveillance from March 2020 until January 2021 in
Uganda, a landlocked East African country with a population of approximately 40 million …

Introductory paragraph SARS-CoV-2 genomic surveillance in Uganda provides an opportunity
to provide a focused description of the virus evolution in a small landlocked East African …

Background: In the last decade, Low-and Middle-Income Countries (LMICs) have set up
Biobanks to collect human biological materials and associated data for genomic research and …

Background Hepatitis E is self-limiting, but can cause death in most at risk groups like
pregnant women and those with preexisting acute liver disease. In developing countries it …

Background Sub-Saharan African countries have a high burden of viral hepatitis and poor
access to screening and care. The aim of this study was to evaluate the feasibility and …

Background: There is uncertainty about the actual burden of childhood TB in Uganda, but
underestimation is acknowledged. We aimed at determining prevalence, factors associated …

Background: Implementation of appropriate informed consent has become a cornerstone for
the use of biological materials and data from clinical care to use in research. During 2017–…

Background Effective management of the COVID-19 pandemic required rapid expansion of
diagnosis. The introduction of antigen tests presented an opportunity to decentralize testing, …

Background Globally response to the SARS-CoV-2 pandemic is highly limited by diagnostic
methods. Currently, World Health Organization (WHO) recommends the use of molecular …